751
Participants
Start Date
October 31, 2010
Primary Completion Date
April 30, 2012
Study Completion Date
May 31, 2012
MenACWY-CRM
This group received a 3-dose primary series at 2, 4, and 6 months of age and a toddler dose at 12 months of age. Approximately half of the subjects had serum collected at Month 3, and the remainder had serum collected at Month 4.
MenACWY-CRM
This group received a 2-dose primary series at 2 and 4 months of age and a toddler dose at 12 months of age.
Routine Vaccines
Each 0.5 mL dose of the pneumococcal 13-valent conjugate vaccine (diphtheria CRM197 protein) is formulated to contain approximately 2.2 μg of each of Streptococcus pneumoniae serotypes 1, 3, 4, 5, 6A, 7F, 9V, 14, 18C, 19A, 19F, 23F saccharides.
Cotton ONeil Clinical Research, Topeka
Cotton ONeil Clinical Research, Topeka
Rockwood Clinic P S, Spokane
Rockwood Clinic P S, Spokane
Birmingham
Fayetteville
Jonesboro
Little Rock
Fountain Valley
Huntington Beach
Madera
Nampa
Bardstown
Bluegrass Clinical Research (Bardstown Road), Louisville
Bluegrass Clinical Research (Brownsboro Park Blvd), Louisville
Springfield
Haughton
Shreveport
Niles
Lincoln
Children's Physicians Dundee, Omaha
Creighton Univ, Omaha
Binghamton
Johnson City
Syracuse
Dayton
Huber Heights
Kettering
Tulsa
Kingsport
Lebanon
San Antonio
Tomball
Layton
Salt Lake City
St. George
Richmond
Greater Sudbury
Toronto
Pierrefonds
Lead Sponsor
Novartis Vaccines
INDUSTRY